findmyKOL
Clinical trialNCT04626024Active, not recruitingPhase 2Interventional

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

SponsorBaylor College of MedicineEnrollment17Chronic Myeloid LeukemiaChronic Myeloid Leukemia in RemissionChronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single-arm, phase II study to evaluate safety and efficacy of tyrosine kinase inhibitor (TKI) cessation for chronic myeloid leukemia (CML) patients with stable molecular response in a real world population.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Baylor College of Medicine- Mcnair Campus

    Houston, Texas, United States

  • Ben Taub General Hospital

    Houston, Texas, United States

  • Chi St. Luke'S Health Baylor College of Medicine Medical Center

    Houston, Texas, United States

  • Harris Health System- Smith Clinic

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Imatinib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Dec 2020
Primary completion
15 Nov 2028
Completion
15 Nov 2028
Last update posted
4 May 2026
Registered enrollment
17
Registry id
NCT04626024
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.